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The adhesion of integrins to the extracellularmatrix is
regulated by binding of the cytoskeletal protein talin
to the cytoplasmic tail of the b-integrin subunit.
Structural studies of this interaction have hitherto
largely focused on the b3-integrin, one member of
the large and diverse integrin family. Here, we employ
NMR to probe interactions and dynamics, revealing
marked structural diversity in the contacts between
b1A, b1D, and b3 tails and the Talin1 and Talin2 iso-
forms. Coupled with analysis of recent structures of
talin/b tail complexes, these studies elucidate the
thermodynamic determinants of this heterogeneity
and explain why the Talin2/b1D isoforms, which are
co-localized in striated muscle, form an unusually
tight interaction. We also show that talin/integrin
affinity can be enhanced 1000-fold by deleting two
residues in the b tail. Together, these studies illus-
trate how the integrin/talin interaction has been
fine-tuned to meet varying biological requirements.
INTRODUCTION
Integrins are large heterodimeric membrane proteins that play
a fundamental role in cell adhesion and migration, linking the
extracellular matrix to the actin cytoskeleton. In the adult, integ-
rins are essential for a variety of biological processes, including
wound healing, leukocyte trafficking, and angiogenesis, and
are thus attractive therapeutic targets for a variety of conditions,
including cancer. Mammals express 18 different a subunits and
8 different b subunits, which form 24 unique ab heterodimers (not
including splice variants). Each a and b chain of the integrin het-
erodimer consists of several linked globular extracellular
domains, a single membrane-spanning helix, and a short cyto-
plasmic tail (Figure 1A) (Hynes, 2002). It has become increasingly
apparent that the cytoplasmic tail of the b subunit modulates
a variety of signaling processes by acting as a hub for protein-
protein interactions (Humphries et al., 2009; Legate and Fassler,
2009; Liu et al., 2000; Shattil et al., 2010). Of particular interest is
the process of inside-out integrin activation, whereby the affinity
of integrins for extracellular ligands is regulated from within the1654 Structure 18, 1654–1666, December 8, 2010 ª2010 Elsevier Ltdcell by the cytoskeletal protein talin (Calderwood, 2004; Camp-
bell and Ginsberg, 2004; Ginsberg et al., 2005).
Talin is a 270 kDa protein that is capable of forming homo-
dimers; it consists of an N-terminal head containing an atypical
FERM domain (comprising F0, F1, F2, and F3 subdomains)
and a C-terminal rod domain that binds to vinculin and actin
(Critchley, 2009; Critchley and Gingras, 2008). Talin activates in-
tegrins through a direct interaction with the b-integrin tail (Cal-
derwood et al., 2002; Tadokoro et al., 2003). The F3 domain of
talin binds to the membrane-distal (MD) portion of the integrin
tail by a typical PTB domain/NPxYmotif interaction (Calderwood
et al., 2003; Garcia-Alvarez et al., 2003). It also binds the
membrane-proximal (MP) helix of the integrin tail (Wegener
et al., 2007) in a manner that is apparently unique to the talin
F3 domain. This talin/b MP interaction disrupts an interaction
between the a- and b-integrin transmembrane and cytoplasmic
domains (Lau et al., 2009), inducing structural rearrangements
in the extracellular portion of the integrin that increase the affinity
for extracellular ligands (Arnaout et al., 2007; Askari et al., 2009).
Although binding of the F3 domain to the b tail is sufficient for in-
tegrin activation (Calderwood et al., 2002), other domains in the
talin head contribute to activation (Bouaouina et al., 2008),
particularly via interactions between the talin F1 (Goult et al.,
2010), F2 (Anthis et al., 2009), and F3 (Wegener et al., 2007)
domains with acidic membrane phospholipids.
Structural studies of integrin activation by talin have, to date,
focused largely on the b3-integrin. Characterization of the integ-
rin/talin interaction has generally been hampered by low affinity
and the poor behavior of integrin peptides in solution, and the
first insight into the interface between the b3 NPxY motif and
the talin F3 domain emerged from a crystal structure of a short
MD fragment of the b3 tail covalently tethered to the Talin1
F2–F3 fragment (Garcia-Alvarez et al., 2003). Further features
of the interface between the b3 MP region and the Talin1 F3
domain were provided by an NMR structure that employed
a chimeric peptide of the b3 MP helix attached to a sequence
from PIPK1g that binds talin tightly (Wegener et al., 2007).
Atomic resolution structures for integrin extracellular domains
have also been dominated by studies on b3 subunits, e.g.,
aVb3 (Xiong et al., 2001, 2002, 2004) and aIIbb3 (Xiong et al.,
2009; Zhu et al., 2008). Likewise, structures of the b3 transmem-
brane domain alone (Lau et al., 2008) and in complex with aIIb
(Lau et al., 2009; Yang et al., 2009) are available, as are struc-
tures of the b3 cytoplasmic tail alone (Vinogradova et al., 2004)
and in complex with aIIb (Vinogradova et al., 2002; WeljieAll rights reserved
Figure 1. The Structure of the Integrin b1D Tail Bound
to Talin2 F2–F3
(A) Sequence of the cytoplasmic regions of the b1A, b1D, and
b3-integrin tails. Residues in b1D and b3 that differ from b1A
are highlighted, and residues of particular significance are
noted using b1 numbering. Secondary structure is based on
the structure of the b1D/Talin2 complex, with a helices de-
noted in blue and 310 helices in green. MP and MD binding
sites are indicated.
(B) Sequence of the F2–F3 domains of Talin1 and Talin2. Resi-
dues in Talin2 that differ from Talin1 are highlighted, and resi-
dues of particular significance are noted using Talin2
numbering. Secondary structure was determined as in (A).
The F2 domain is underlined in cyan and the F3 in yellow.
(C) The crystal structure of Talin2 F2–F3 bound to the b1D-in-
tegrin tail (3G9W) published previously (Anthis et al., 2009) is
shown here for illustrative purposes, with significant b1D resi-
dues highlighted.
See also Figure S3. All structure images were generated with
MOLMOL (Koradi et al., 1996).
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Integrin/Talin Interaction Structural Diversityet al., 2002). Structural data have not previously been available
for any other b subunits, although our recent structure of the
b1D/Talin2 complex (Anthis et al., 2009) and a structure of
aXb2 (Xie et al., 2010) have begun to address this imbalance.
Consideration of structure/function relationships among
different integrins is important because the eight different
b subunits (plus additional splice variants) expressed in
mammals have nonredundant functions and show unique tissue
distributions, ligand specificities, and a binding partners (Hynes,
2002).
The b1-integrin, which is widely expressed, plays key roles in
a variety of biological processes, and knockout of this gene in
mice is embryonic lethal (Fassler and Meyer, 1995). The b3-in-
tegrin, on the other hand, is of significance primarily in the blood
and vasculature, and b3-integrin null mice exhibit a bleeding
defect (Hodivala-Dilke et al., 1999). Replacement of the b3 tail
with that of b1 increases basal aIIbb3-integrin activation levels
(Hato et al., 2008; O’Toole et al., 1994), an observation that is
consistent with the general idea that the aIIbb3-integrin exists
in a default ‘‘off’’ state and is only activated during thrombosis.
In contrast, b1-integrins generally exist in a more active confor-
mation, consistent with their role in adherent cells.Structure 18, 1654–1666, DecembeAnother difference between b1- and b3-integrin
activation is that the isolated Talin1 F2–F3 domain
pair can activate aIIbb3; in contrast, a5b1 activation
requires additional domains from the talin head
region, particularly the F0 domain (Bouaouina
et al., 2008). This difference could arise from differ-
ences in the b-integrin MP region, although the
sequences of b1 and b3 are very similar here (Fig-
ure 1A). Only one of the differing residues in this
region makes contact with talin in the b3-PIPK1g/
Talin1 structure (Wegener et al., 2007), and this
residue (b3 R734, b1 K770) is a conservative substi-
tution. Thus, current structural data do not explain
observed differences in talin-mediated activation
between these two integrins.
An additional observation that remains unex-
plained is that b1D, a splice variant of b1, binds talinwith higher affinity than b1A (Anthis et al., 2009; Belkin et al.,
1997), although these isoforms only differ significantly in the
extreme C-terminal region of their cytoplasmic tails (Figure 1A).
b1D is expressed primarily in striated muscle cells (Belkin
et al., 1996) and is found in the myotendinous junction where it
co-localizes with the Talin2 isoform (Conti et al., 2008, 2009),
which is also highly expressed in striated muscle (Monkley
et al., 2001; Senetar et al., 2007). The sequence identity between
the tails of b1A and b1D (and b3) (Figure 1A) and between the F3
domains of Talin1 and Talin2 (Figure 1B) is high, so the reason for
the different affinities is not clear from previous studies.
To explore these intriguing biological differences, we studied
the interaction between talin and the cytoplasmic tails of
different integrins using NMR, X-ray crystallography, isothermal
titration calorimetry (ITC), and mutagenesis. These investiga-
tions have revealed significant structural diversity in integrin/talin
interactions, enabling us to offer novel explanations for some of
the biological observations, including the high affinity of the
muscle-specific b1D/Talin2 complex and differences between
b1 and b3. In addition the role of conformational entropy in
complex formation emerges from observations of differences
in rigidity of the MP regions of different integrins. The fact thatr 8, 2010 ª2010 Elsevier Ltd All rights reserved 1655
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and integrin tails is demonstrated by data showing that relatively
minor mutations in the tail can increase the talin affinity by
1000-fold. These findings illustrate common themes and signifi-
cant differences in the interactions between the talin and integrin
isoforms found in mammals.
RESULTS
Diversity in Integrin/Talin Interactions Revealed by NMR
NMR experiments using 15N-labeled b1A-, b1D-, and b3-integrin
cytoplasmic tails have revealed widely different affinities
between these different integrins and the two isoforms of talin
(Anthis et al., 2009). In particular the b1D/Talin2 pair exhibits
a much higher affinity than any other wild-type (WT) integrin/talin
pair (Table 1; see Figure S1 available online), and this enabled us
previously to determine the first crystal structure of a fragment of
talin (the F2–F3 domain pair) bound to an authentic full-length in-
tegrin tail (Anthis et al., 2009) (Figure 1C).
The chemical shift perturbation maps produced by NMR (Fig-
ure 2) reveal striking differences in the interaction surfaces
between different talin and integrin isoforms. In particular the
F3 domains of both talin isoforms induce larger chemical shift
perturbations in the MP region of the b3 tail than they do in the
b1 tails, whereas larger perturbations are induced in the MD
region of b1 tails than in the b3 tail. Mutation of two phenylalanine
residues in b3 (FF727/730AA) inhibits activation of aIIbb3 by dis-
rupting the interaction of Talin1 with the MP portion of the b3 tail
(Wegener et al., 2007). Here, we show that this mutation abro-
gates the Talin1-induced shift perturbations in the MP region of
b3 (Figure 3B) and decreases the affinity of the interaction by
5.0 kJ/mol (Table 1). The analogous mutation in b1A (FF763/
766AA) also abrogates Talin1-induced MP perturbations
(Figure 3A) and decreases the affinity of the interaction by
2.4 kJ/mol (Table 1).
It is informative to divide up the various contributions to the
binding energy, which can be considered additive to a first
approximation because the MP and MD regions are relatively
well separated, and there is little evidence for synergy or cooper-
ative effects. Contributions to the MD portion of the interaction
can be judged bymutating the tyrosine residue in the NPxYmotif
(Y747 in b3, Y783 in b1A); this abrogates the MD perturbations
and decreases the affinity of Talin1 for both integrins (Figure 3),
although the effect is greater on b1A than on b3 by 1.9 kJ/mol
(Table 1). A significant fraction of the binding energy also comes
from the tryptophan located between the MP and MD binding
surfaces (W775 in b1, W739 in b3; Figure 1 and Table 1). The
affinity of the Talin1 F3 domain for b3 has a relatively large contri-
bution from the MP region (24% of binding energy for b3 versus
13% for b1A), whereas the MD portion contributes more to b1A
binding (30% for b1A, versus 19% for b3). The dominant effect of
the NPxY motif is even more pronounced for b1D where 45% of
binding affinity is lost upon mutation of Y783.
Binding Differences Revealed by the Structure
of the b1D/Talin2 Complex
The recent structure of the full-length b1D-integrin tail bound to
the F2–F3 domains of Talin2 (Anthis et al., 2009) (PDB 3G9W)
(Figure 1C) revealed that the first 37 residues of the b1D tail1656 Structure 18, 1654–1666, December 8, 2010 ª2010 Elsevier Ltd(K752–N788) form a large (1300 A˚2) elongated interface with
the F3 domain of Talin2, consisting of two well-defined regions.
The MP interface is largely hydrophobic, whereas the MD inter-
face contains numerous hydrogen bonds. The linker between
these regions (D776–E779) exhibits weaker electron density
and multiple conformations (Figure S3), and the 13 residues at
the C terminus are not visible in the structure. The MP interface
of the integrin tail forms a well-defined helix (Anthis et al.,
2009). We now focus on the differences between integrin/talin
complexes.
The greatest differences observed between the b1D/Talin2
structure and previous b3/Talin1 structures lie in the MD portion
of the integrin tail. An overlay of the MD region of the b1D/Talin2
structure with analogous regions from b3 and two other NPxY-
like peptides, layilin (Wegener et al., 2008) and PIPK1g (Wegener
et al., 2007) (Figure 4A) bound to Talin1, reveals that these
peptides exhibit strikingly different orientations (Figure 4B). The
overlay also reveals a loop (D776–Q778) that protrudes from
the b1D structure betweenW775 and the NPxYmotif (Figure 4B).
However, in b3 the extra residues are accommodated by
a unique orientation of the NPxY motif (Figure 4B). Interestingly,
the two nonintegrin peptides, which bind talin with higher affinity
(Barsukov et al., 2003; de Pereda et al., 2005; Wegener et al.,
2008), have a linker sequence that is two residues shorter than
that found in integrins (Figure 4A). Replacement of the two addi-
tional residues in b1D with the shorter sequence from layilin, i.e.,
b1D residues D776, T777, and Q778 were replaced with a single
valine residue ((D776/T777/Q778)V), dramatically increased the
affinity of b1D for Talin2 and pushed the kinetics of the interac-
tion into the slow exchange regime (Figures S1C and S1D), too
tight for accurate affinity determination by NMR. The Kd
measured by ITC instead (Figure 5A) was 17 nM, 1000-fold
tighter than that of Talin2/b1D WT (Kd = 20.4 mM) measured by
the same technique. These values were consistent in indepen-
dent experiments (Figures 5B and 5C) and comparable to the
values determined by NMR (Table 1). The increase in binding
energy (17.5 kJ/mol) caused by the mutation can be attributed
to a change in the favorable enthalpy component of the free
energy, from an average of DH = 71.3 kJ/mol for the WT tail
to DH = 92.2 kJ/mol for the mutant (Figure 5). The entropy
component, on the other hand, remained unfavorable and was
only slightly perturbed by the mutation (149 J/mol/K for the
WT tail and 160 J/mol/K for the mutant).
A more detailed comparison of the interaction of the MD
portions of b1D and b3 with talin yields additional insights. In
particular there are more intermolecular hydrogen bonds
between b1D and Talin2 (11) than between b3 and Talin1 (7) in
this region (Figures 4C and 4D), although the residues involved
are largely conserved between isoforms. The structure implies
that b1 E779 (N743 in b3) may be in a position to form a salt
bridge with Talin2 K360 (K357 in Talin1; Figure 6E), although
the electron density for this residue was weak. The other residue
that differs in the MD portion is b1 I782, which forms extensive
contacts with Talin2. Analysis of FF/AA and Y/A mutants (Table
1 and Figure 3) suggests that the affinity of Talin1 for the MD
portion of b1A is 1.1–1.9 kJ/mol greater than that of b3. Mutating
these two residues in b1A to their b3 counterparts (i.e., b1A
E779N/I782L) reduces the affinity of the b1A/Talin1 interaction
by 1.5 kJ/mol. Introducing the opposite mutations in b3All rights reserved
Table 1. Affinity of b Tail Mutants for WT Talin F3 Domains
Mutation Kd (mM)
a DG (kJ/mol)b DDG (kJ/mol)c DDG (%)d
b1A + Talin1
WT 491 ± 10 18.88 ± 0.05 – –
FF763/766AA 1280 ± 57 16.50 ± 0.11 2.37 13
K768E 324 ± 7.7 19.91 ± 0.06 1.03 5
K768E/K770R 253 ± 5.6 20.52 ± 0.05 1.64 9
W775A 6500 est.e 12 6 34
E779N 767 ± 21 17.77 ± 0.07 1.11 6
E779N/I782L 882 ± 23 17.42 ± 0.06 1.45 8
I782L 556 ± 14 18.57 ± 0.06 0.31 2
Y783A 5000 est. 13 6 30
S785E 494 ± 21 18.86 ± 0.11 0.02 0
b1A + Talin2
WT 652 ± 20 18.18 ± 0.08 – –
b1D + Talin1
WT 95 ± 4.1 22.95 ± 0.11 – –
b1D + Talin2
WT 36 ± 2.3 25.36 ± 0.16 – –
FF763/766AA 58 ± 2.9 24.19 ± 0.12 1.17 5
W775A 258 ± 7.8 20.47 ± 0.07 4.88 19
Y783A 3700 est. 14 11 45
S785E 71 ± 5.3 23.66 ± 0.19 1.69 7
WTf 20.4 ± 1.1 26.76 ± 0.14 – –
(D776/T777/Q778)Vg 0.017 ± 0.005 44.3 ± 0.7 17.5 69
b3 + Talin1
WT 273 ± 6.4 20.33 ± 0.06 – –
FF727/730AA 2027 ± 73 15.36 ± 0.09 4.97 24
E732K 538 ± 17 18.65 ± 0.08 1.68 8
E732K/R734K 748 ± 27 17.83 ± 0.09 2.50 12
R734K 374 ± 6.8 19.55 ± 0.05 0.78 4
A735M 243 ± 4.2 20.61 ± 0.04 0.28 1
R736N 279 ± 5.1 20.27 ± 0.05 0.06 0
W739A 6600 est. 12 8 39
N743E/L746I 201 ± 5.4 21.09 ± 0.07 0.76 4
Y747A 1317 ± 36 16.43 ± 0.07 3.90 19
b3 + Talin2
WT 438 ± 15 19.16 ± 0.09 – –
See also Figure S1.
a Kd values were determined by NMR unless otherwise noted and are given ± fitting error.
bDG is given for binding and calculated from Kd.
cDDG (kJ/mol) is the DG value for the mutant integrin binding to talin, minus the DG value for the WT integrin binding to talin (a positive value denotes
a decrease in affinity).
dDDG (%) is the percentage of binding energy lost (or gained) by the given mutation (a positive value denotes a decrease in affinity).
e Approximate Kd values were estimated by comparing magnitude of chemical shift perturbations to those in the WT titration, as described in Exper-
imental Procedures.
f Kd value determined by ITC and given as an average of two independent experiments. The error includes the standard error of this value and the two
respective fitting errors.
g Kd value determined by ITC and given ± fitting error.
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Integrin/Talin Interaction Structural Diversity(N743E/L746I) increases the affinity by 0.8 kJ/mol (Table 1).
Thus, affinity differences in the MD region are largely explained
by E779 and I782. This is consistent with the chemical shift
perturbation maps of b1A E779N/I782L, which resemble thoseStructure 18, 1654–16of b3 WT; the shift map of this region in b3 N743E/L746I is also
similar to that of b1A WT (Figure S4).
In the b1D/Talin2 structure, Talin2 Y376 is packed against b1D
P786, and it participates in hydrogen bonding with the b1D66, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1657
Figure 2. Diversity in Integrin/Talin Interactions Observed
by NMR
Weighted chemical shift maps of perturbations observed in 1H-15N
HSQC spectra of the b1A (A), b1D (B), and b3 (C) tails (50 mM) upon
addition of the Talin1 or Talin2 F3 domains (1mM).MP andMDbinding
sites are indicated at the bottom of the figure. The shift map for b1D
with Talin2 has been cropped, and the full map can be seen in Fig-
ure S2. Most of the interactions studied here exist in the fast-interme-
diate chemical exchange regime, so resonances that experience
a particularly large change in position upon binding are subject to
extensive broadening and could not be tracked. These are denoted
by the lighter gray bars in the chemical shift maps presented
throughout this study. No other dynamic processes were observed
in these studies that would contribute to broadening, so it can be
assumed that these lighter bars correspond to residues with similar
or larger magnitude shifts than the highest bars in these plots.
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Integrin/Talin Interaction Structural Diversitybackbone. However, in the b3/Talin1 structure this tyrosine
(Y373), and the loop it is located in, does not make contact
with b3 (Figure 4D). The Y376A mutation had a significant effect
on the affinity of the interaction of Talin2 with b1D, a slightly
smaller effect on the interaction with b1A, and a still smaller
effect on the interaction with b3 (Table 2), consistent with the
structural data. The above interaction brings b1D S785 in posi-
tion to hydrogen bond with Talin2 E375, and mutation of S785
to the glutamate found in the b3 tail reduces the energy of b1D
binding to Talin2 by 1.7 kJ/mol (Table 1).
b1D/Talin2 Specificity Explained
The cytoplasmic tails of b1A and b1D differ in two regions (Fig-
ure 1A): b1A has a glycine and b1D a glutamine at position
778; the two tails then differ extensively in their C termini from
position 786 onward. Residue Q778 has weak electron density
in the b1D/Talin2 structure (Figure S3), but NMR chemical shift
mapping experiments reveal much larger perturbations in the
b1D/Talin2 titration than in the b1A/Talin1, b1A/Talin2, and
b1D/Talin1 titrations (Figure 2). Consistent with this, site-directed1658 Structure 18, 1654–1666, December 8, 2010 ª2010 Elsevier Ltd All rigmutagenesis and affinity measurements show that posi-
tion 778 explains about 35% of the difference in affinity
between b1A and b1D for both talin isoforms (Table 3)
and, thus, plays a significant role in the binding.
In the b1D/Talin2 structure, P786 in b1D packs against
Y376 in Talin2, forming a hydrophobic interface (Figures
6A and 6B). An extensive hydrogen bonding network,
including b1D Y783 and S785, Talin2 E375, and both
backbones, is also formed at the interface. Site-directed
mutagenesis of b1D P786, which is an alanine in b1A,
reveals that it contributes about 53% of the difference
between the tails for binding to Talin1 and 56% of the
difference for binding to Talin2 (Table 3). Thus, P786 is
the major contributor to the high b1D binding affinity.
Although the difference in talin affinity for b1Aand b1D is
large and significant (4.07 kJ/mol for Talin1 and
7.18 kJ/mol for Talin2; Table 3), there is also a smaller
difference (2.41 kJ/mol) in binding of b1D to Talin1 and
Talin2 (Table 1). A likely candidate for the source of this
difference is Talin2 E375 (D372 in Talin1), which is involved
in numerous intermolecular interactions (Figures 6A
and 6B). Although a conservative substitution, the shorterside chain produced by the E/D mutation could disrupt the
optimal geometry of this interaction. Site-directed mutagenesis
reveals that position 375explains 57%of thedifference inbinding
energy between Talin1 and Talin2 (Table 2). Two other nearby
Talin2-to-Talin1 mutations (P355S and T358N) cause smaller
effects, as does S392A. These latter three residues form Talin2-
specific intramolecular hydrogen bonds that could help stabilize
the optimal geometry of Talin2 for this interaction (Figure 6).
Entropic Basis of MP Binding Differences
How do differences in talin binding to the MP region of b1- and
b3-integrins relate to observed differences in integrin activation
(Bouaouina et al., 2008; Hato et al., 2008)? The structure of the
MP region of b1D bound to Talin2 is highly similar to that of the
MP region of b3 bound to Talin1 (Figures 7A and 7B), making
this a vexing question. Only one of the changed residues in
this region makes significant contact with talin (b3 R734/b1
K770), and this is a conservative substitution. A clue to the basis
of these binding differences emerged from NMR-based back-
bone dynamics studies. Heteronuclear NOE experiments ofhts reserved
Figure 3. Mutations that Specifically Disrupt the MP or MD
Portions of the Integrin/Talin Interaction
Chemical shift maps of b1A (A) and b3 (B) tails were generated as in
Figure 2 but with mutants affecting either the MP portion of the inter-
action (FF/AA) or the MD portion of the interaction (Y/A). Portions of
these data have been published previously (Anthis et al., 2009) but
are shown here for completeness. See also Figure S4.
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dynamics and largely unstructured peptides (Figures 7C
and 7D). However, part of the MP region in b3 is less flexible
than the same region in b1A and b1D (Figure 7C). Such a differ-
ence in dynamics could partly explain the observed differences
in talin binding because there would be a decreased entropic
cost for b3 binding to talin compared to b1.
This observation was followed up to see if mutation of this
region could make b3 behave like a b1-integrin, and vice versa.
Four residues in this region differ between b3 and b1. To explore
their influence the following b3 mutants were constructed:
E732K, R734K, A735M, and R736N. Although A735M and
R736N have only minimal effects on b3 affinity for Talin1,
E732K and R734K cause more significant changes (Table 1).
The double E732K/R734Kmutation demonstrates that this effect
is additive, decreasing Talin1 binding affinity by 2.5 kJ/mol. Like-
wise, the b1A K768E/K770R mutation, to make it more b3-like,
increases the binding affinity by 1.6 kJ/mol. Mutagenesis
suggests that the affinity of Talin1 for the MP portion of b3 is
2.6–3.3 kJ/mol higher than for b1A (Table 1). Thus, these muta-Structure 18, 1654–1666, Detions reverse most of the difference in binding affinity
between the MP regions of the b1A and b3 tails. Consis-
tent with this, the two mutant integrins exhibited NMR
dynamics intermediate between those of the b3 and
b1A WT tails (Figure 7D).
Analysis of the helical propensity of these peptides
using Agadir (Munoz and Serrano, 1994) provides addi-
tional evidence that these two residuesdetermine the rela-
tive rigidity of this portion of the integrin. An overall helical
content of 6.47% is predicted for theWT b3 tail sequence,
but only 1.65% after the double E732K/R734K mutation
(Figures 7E and 7F). The b1A tail, on the other hand, has
a predicted 0.83% helical content (increased to 2.19%
after the opposite double mutation). In fact, talin-binding
affinity displays a direct correlation with helical propensity
for a variety of mutations in the MP region of the b1A and
b3-integrin tails (Figure S5). These observations on
a-helical propensity, dynamics, and affinity in the MP
region of b tails strongly suggest that conformational
entropy plays an important role in talin binding, with a pre-
formed helix binding more readily than a disordered one.
DISCUSSION
Analysis of known structures of the b1D/Talin2 and b3/Ta-
lin1 complexes, together with new NMR-based experi-
ments, reveals striking differences between the
interactions of different b-integrin tails with the two talin
isoforms. NMR studies show that the b3 tail largely relies
on an interaction with the MP region for its talin bindingaffinity, whereas b1 relies more on the MD region. Differences
in binding to the MP region mainly arise from entropic effects,
whereas the MD differences arise from differences in enthalpy.
Structural differences in the MD region are relatively large,
with, for example, the NPxY motifs adopting different orienta-
tions (Figure 4). In contrast the structure of the MP portion of
this interaction is similar in the different complexes. This implies
that the MD region provides tunable affinity, whereas the MP
region is directly involved in activation, an idea also supported
by the recent finding that mutation of b3 residues E726 and
E733 in the b3 MP helix, which form precise electrostatic
contacts between talin and the b3 MP helix, more severely
disrupts integrin clustering than the MD mutation Y747A (Saltel
et al., 2009).
Further support for this idea comes from the observation that
the tighter affinity of talin for b1D-integrin arises from interactions
in the MD region. Most of the difference in affinity between b1A
and b1D is explained by b1D P786 (alanine in b1A). This residue
forms an extensive hydrophobic interface with Talin2 Y376 (Y373
in Talin1), stabilizing a favorable b1 hydrogen-bonding networkcember 8, 2010 ª2010 Elsevier Ltd All rights reserved 1659
Figure 4. Diversity in NPxY Motif Binding
to Talin
Sequence (A) and structure (B) alignments of four
NPxY motifs bound to the Talin1 or Talin2 F3
domain. The b1D-integrin tail (red, PDB 3G9W)
(Anthis et al., 2009) is compared with b3 (magenta,
PDB 1MK9) (Garcia-Alvarez et al., 2003), layilin
(green, PDB 2K00) (Wegener et al., 2008), and
PIPK1g (blue, PDB 2H7E) (Wegener et al., 2007).
In each case the backbone of the talin F3 domain
was aligned to the talin F3 backbone in the Talin2/
b1D structure. The bottom panels compare the
MD region of the Talin2/b1D complex (C) with
that of the Talin1/b3 complex (1MK9) (D), shown
in the same orientation (based on the talin back-
bone) to highlight the different integrin arrange-
ments. Talin is shown in yellow and the integrin
tail in red. Intermolecular hydrogen bonds are
highlighted in cyan. Residues that have been
mutated in this study are shown in blue (integrin)
or green (talin). Selected aspects of the Talin2/
b1D structure can be seen in greater detail in Fig-
ure 6. We note that the b1D/Talin2 structure was
solved by X-ray crystallography to a resolution of
2.2 A˚; the b3/Talin1 structure shown here was
solved to a resolution of 2.8 A˚ (and another,
1MK7, to 2.2 A˚). Therefore, the broad structural
differences illustrated here are within the range of
what can be reliably observed from such data.
The two nonintegrin structures shown, on the
other hand, were solved by NMR.
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affinity is Q778 (glycine in b1A). Talin2 binds to b1D more tightly
than Talin1, partly because a glutamate at position 375, as
opposed to an aspartate residue, gives a better geometry
(Figure 6).
In striatedmuscle, b1D-integrin predominates over b1A, Talin2
is more abundant than Talin1, and b1D and Talin2 co-localize in
the myotendinous junction (Conti et al., 2008). The fact that
among b-integrins, b1D and Talin2 form the tightest known
complex is consistent with a role in withstanding the forces ex-
erted on the myotendinous junction during muscle contraction.
Indeed, although mice lacking Talin2 are viable, they develop
a dystrophic phenotype that is significantly more severe than
that arising from loss of Talin1 (Conti et al., 2009). However,
loss of both Talin1 and Talin2 leads to major defects in myoblast
fusion and sarcomere assembly, indicating that the two talin iso-
forms have overlapping but nonredundant functions in striated
muscle.
The Talin2/b1D structure is the first atomic-resolution talin/in-
tegrin structure involving a full-length integrin tail peptide; the
earlier Talin1/b3 structures were obtained using chimeras (Gar-1660 Structure 18, 1654–1666, December 8, 2010 ª2010 Elsevier Ltd All rights reservedcia-Alvarez et al., 2003; Wegener et al.,
2007). The data presented here are
consistent with real structural differences
in those portions of the complexes that
correspond to ‘‘authentic’’ sequences.
Based on these results, differences in
binding energetics between different ta-
lin/integrin pairs can be ascribed tospecific structural features, particularly in the MD portions of
the integrin tails. For example, mutagenesis demonstrates that
the proline at b1D position 786 increases its Talin2 affinity by
4.0 kJ/mol compared to the alanine found in b1A. This is roughly
equivalent to the difference in solvation energy expected for
a fully buried proline versus alanine (3.8 kJ/mol) (Wimley et al.,
1996). The surrounding hydrogen-bonding network also plays
a role, as evidenced by the fact that b1D P786 only adds
2.2 kJ/mol over b1A A786 in affinity for Talin1, which lacks
a key hydrogen-bonding residue (E375) found in Talin2.
Comparing b1A with b3 is more complex due to the more
dramatic differences in their interfaces with talin. Significantly,
b1A forms more hydrogen bonds with talin than b3. Although
the residues involved are largely conserved between isoforms,
a single hydrogen bond could contribute 6 kJ/mol to the interac-
tion (Pace et al., 1996), and a salt bridge (e.g., involving E779 in
b1) could contribute 15 kJ/mol (Kumar and Nussinov, 1999);
either would be more than sufficient to explain the observed
differences in affinity of talin for the MD portions of the tails.
Because these interactions occur on a solvent-exposed surface,
the contribution of each electrostatic interaction would be
Figure 5. ITC Analysis of the Talin2/b1D Interaction
ITC experiments were performed by titrating b1D tail (WT and layilin-like linker mutant) with increasing amounts of Talin2 F3 domain. (B) and (C) show two inde-
pendent b1D WT experiments; the results were reproducible, with Kd values varying 8.9% between the experiments, DH varying 4.7%, and DS varying 6.9%.
(A) A solution of 5 mM b1D (D776/T777/Q778)V injected with 50 mM Talin2 WT. Fitting the data to a 1:1 binding model gave: Kd, 17.2 ± 5.0 nM; DH, 92.2 ±
1.6 kJ/mol; and DS, 160 J/mol/K.
(B) A solution of 149 mM b1D WT injected with 1.87 mM Talin2 WT (Kd, 21.3 ± 0.5 mM; DH, 69.66 ± 0.60 kJ/mol; and DS, 144 J/mol/K).
(C) A solution of 139 mM b1D WT injected with 1.99 mM Talin2 WT (Kd, 19.4 ± 0.2 mM; DH, 72.94 ± 0.23 kJ/mol; and DS, 154 J/mol/K).
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mitigate their contributions.
Before forming a complex with talin, the b tails are essentially
disordered, with some helical propensity in the MP region, as
shown by the NMR dynamics studies reported here (Figure 7)Structure 18, 1654–16and consistent with previous reports on b3 (Li et al., 2002; Ulmer
et al., 2001; Vinogradova et al., 2004). Disordered protein regions
often act as ‘‘hubs’’ for promiscuous interactions with several
different partners; the disorder gives rise to weak but specific
interactions (with rapid kinetics) because of an entropic cost inFigure 6. The Structural Basis of b1D/Talin2 Speci-
ficity
(A) The portion of the b1D/Talin2 complex including b1D Y783,
S785, and P786, and Talin2 E375 and Y376. Talin2 is shown in
yellow and b1D in red. Intermolecular hydrogen bonds are
shown in cyan.
(B) The same view as (A) but with Talin2 shown in space-filling
form to illustrate the interface between Talin2 Y376 and b1D
P786.
(C) Talin2 T358, shown forming a hydrogen bond from its side
chain to the P355 backbone.
(D) Talin2 S392, shown forming a hydrogen bond from its side
chain to the G388 backbone.
(E) The portion of the complex including b1D E779 and
Talin2 K360.
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Table 2. Affinity of WT b Tails for Talin2 F3 Domain Mutants
Mutation
Kd
(mM)a
DG
(kJ/mol)b
DDG
(kJ/mol)c
DDG
(%)d
DDG1-2
(%)e
b1A
WT 652 ± 20 18.18 ± 0.08 – – –
Y376A 3600 est.f 14 4 23 –
b1D
WT 36 ± 2.3 25.36 ± 0.16 – – –
P355S 51 ± 2.5 24.50 ± 0.12 0.85 3 35
T358N 50 ± 2.6 24.54 ± 0.13 0.82 3 34
E375D 63 ± 3.0 23.98 ± 0.12 1.38 5 57
Y376A 698 ± 23 18.01 ± 0.08 7.35 29 –
S392A 54 ± 2.7 24.33 ± 0.12 1.03 4 43
Q407K 39 ± 2.0 25.15 ± 0.13 0.21 1 9
b3
WT 438 ± 15 19.16 ± 0.09 – – –
Y376A 898 ± 26 17.38 ± 0.07 1.78 9 –
a Kd values were determined by NMR and are given ± fitting error.
bDG is given for binding and calculated from Kd.
cDDG (kJ/mol) is the DG value for the mutant integrin binding to talin,
minus the DG value for the WT integrin binding to talin (a positive value
denotes a decrease in affinity).
dDDG (%) is the percentage of binding energy lost (or gained) by the given
mutation (a positive value denotes a decrease in affinity).
eDDG1–2 (%) is the percentage of the difference in binding energy
between Talin1 and Talin2 covered by the given mutation.
f Approximate Kd values were estimated by comparing magnitude of
chemical shift perturbations to those in the WT titration, as described in
Experimental Procedures.
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Integrin/Talin Interaction Structural Diversityforming the complex (Kriwacki et al., 1996; Tompa et al., 2009).
Consistent with this idea, ITC data (Figure 5) demonstrate that
the free energy of integrin/talin binding is dominated by a highly
favorable enthalpy term, compared to an unfavorable entropy
term. The importance of disorder in complex formation is illus-
trated here by the observation of differences in rigidity of the
MP regions of different integrins.
NMR-based studies have shown that changes in conforma-
tional entropy during protein-protein interactions exert a signifi-
cant effect on the overall DG of the process, affecting the affinity
of the interaction (Frederick et al., 2007; Marlow et al., 2010). The
relevance here is that relatively small differences in disorder
correlate with significant differences in talin-binding affinity
between the MP regions of b1- and b3-integrins. Such differ-
ences in affinity may explain the observation that the Talin1
F2–F3 domain pair alone is able to activate aIIbb3 but not a5b1
(Bouaouina et al., 2008) and the fact that a b3 chimeric integrin
with a b1 tail is more active than WT b3 (Hato et al., 2008).
Because the MP portion of the talin/integrin interaction directly
leads to integrin activation, changes in affinity in that region
would have a major influence on the activation process. Thus,
intrinsic flexibility of the tail in the uncomplexed state may be
one mechanism that integrins employ to fine-tune them for
specific biological roles.
Integrins also exhibit a two-residue insert between
a conserved tryptophan and the NPxY motif compared to other
talin-binding NPxY-type peptides (Figure 4). This insert consid-1662 Structure 18, 1654–1666, December 8, 2010 ª2010 Elsevier Ltderably decreases the affinity of integrin tails for talin compared
to these other peptides; the removal of these extra residues
leads to a marked increase in affinity (Table 1) and greatly slows
the kinetics of the interaction (Figure S1). Thus, despite these
extra residues and intrinsic flexibility being suboptimal for high
talin-binding affinity, it seems that biology has optimized the in-
tegrin-talin interaction to be relatively weak and highly transient.
Processes such as cell migration require the integrin/talin inter-
action to be tight enough to promote activation but not so tight
that integrins remain constitutively active.
In summary the data presented here indicate that significant
structural diversity exists in the way different integrins interact
with talin and that these differences correlate with different bio-
logical activities. Despite these differences, the integrins share
many characteristics, such as intrinsic disorder in the C
terminus, which we suggest is a key way of fine-tuning cell adhe-
siveness. Further experimental work will be needed to explore to
what degree each of the structural features explored here
contributes to integrin activation in the more complex context
of a living cell. Becausemuch previous work has focused specif-
ically on the b3-integrin, in the future it will be important to
consider a more nuanced picture of integrin activation.
EXPERIMENTAL PROCEDURES
Preparation and Purification of Proteins
All proteins and peptides were expressed in E. coli and purified as reported
previously (Anthis et al., 2009). Full-length integrin tails were produced in
pET16b using the following boundaries: b1A K752-K798, b1D K752-L801,
and b3 K716-T762. Talin F3 domain constructs were produced in pGEX-6P-
2 using the following boundaries: Talin1 G309-S405 and Talin2 G312-S408.
Mutations were introduced using the QuikChange kit (Stratagene).
NMR Spectroscopy
NMR experiments were performed on spectrometers equipped with Oxford
Instruments’ superconducting magnets (500, 600, 750, and 950 MHz 1H oper-
ating frequencies) and a Bruker 500 MHz instrument with a cold probe.
Samples were prepared in NMR buffer (50 mM sodium phosphate, 100 mM
NaCl, and 1 mM DTT [pH 6.1]) with 5% D2O and Complete protease inhibitors
(Roche). Experiments were performed at 25C. The 1H and 15N resonances of
U-15N-labeled b-integrin tails were previously assigned and deposited in the
Biological Magnetic Resonance Bank under the following accession
numbers: 16159 (b1A); 16158 (b1D) (Anthis et al., 2009); and 15552 (b3) (Oxley
et al., 2008). Spectra were referenced in the direct dimension to DSS (2,2-
dimethyl-2-silapentane-5-sulfonate) at 0 ppm, with indirect referencing in
the 15N dimension using a 15N/1H frequency ratio of 0.101329118 (Wishart
et al., 1995). Data were processed using NMRPipe (Delaglio et al., 1995),
and spectra were visualized using SPARKY (www.cgl.ucsf.edu/home/
sparky).
Heteronuclear steady-state {1H}-15N NOE experiments (Kay et al., 1989)
were conducted at a 600 MHz 1H operating frequency on samples containing
0.2–0.25 mM integrin tail. The heteronuclear NOE value was calculated for
each peak as Is/I0, where Is is peak intensity with saturation, and I0 is intensity
without saturation.
NMR Protein-Protein Interaction Studies
1H-15N HSQC titrations were performed with 0.05 mM U-15N-labeled integrin
tail and increasing concentrations of unlabelled talin, from 0 to 1mM.Weighted
combined 1H and 15N amide shifts (D(H,N)) were calculated using the equation:
DðH;NÞ=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
DHW2H +DNW
2
N
q
;
where WH and WN are weighting factors for the
1H and 15N amide shifts,
respectively (WH = 1, WN = 0.154) (Ayed et al., 2001), and D = dbound  dfree.All rights reserved
Table 3. Affinity of b1A versus b1D for Talin F3 Domains
Mutation Kd (mM)
a DG (kJ/mol)b DDGAD (kJ/mol)
c DDGAD (%)
d
Talin1
Position 778
b1A G778Q 312 ± 6.5 20.00 ± 0.05 1.12 28
b1D Q778G 193 ± 5.2 21.19 ± 0.07 1.76 43
Average 1.44 35
Position 786
b1A A786P 243 ± 7.5 20.62 ± 0.08 1.75 43
b1D P786A 269 ± 5.7 20.37 ± 0.05 2.58 63
Average – 2.16 53
Both Positions
b1A G778Q/A786P 135 ± 5.3 22.08 ± 0.10 3.20 79
b1D Q778G/P786A 388 ± 8.5 19.46 ± 0.05 3.49 86
Average 3.34 82
b1A versus b1D
Actual difference 4.07 –
Talin2
Position 778
b1A G778Q 236 ± 5.4 20.69 ± 0.06 2.52 35
b1D Q778G 97 ± 3.7 22.90 ± 0.09 2.45 34
Average 2.48 35
Position 786
b1A A786P 127 ± 6.2 22.23 ± 0.12 4.05 56
b1D P786A 176 ± 4.7 21.42 ± 0.07 3.94 55
Average 4.00 56
Both Positions
b1A G778Q/A786P 57 ± 3.5 24.19 ± 0.15 6.02 84
b1D Q778G/P786A 369 ± 7.4 19.59 ± 0.05 5.77 80
Average 5.89 82
b1A versus b1D
Actual difference 7.18 –
aKd values were determined by NMR and are given ± fitting error.
bDG is given for binding and calculated from Kd.
cDDGAD (kJ/mol) gives the amount by which the free energy of binding is decreased when the b1D residue is mutated to the b1A residue, regardless of
which integrin tail the mutation was made in. Therefore, this value will always be positive.
dDDGAD (%) is the percentage of the difference in binding energy between b1A and b1D covered by the given mutation.
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chemical shift upon increasing talin concentration to the following equation:
DðH;NÞ=DðH;NÞmax
½L+ ½U+Kd 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð½L+ ½U+KdÞ24½L½U
q
2½L
where Kd is the dissociation constant, D(H,N) is the weighted shift change,
D(H,N)max is the shift change at saturation, and [L] and [U] are the concentra-
tions of the labeled and unlabeled proteins, respectively. Data from peaks that
were well resolved, had a significant change in position, and were discernable
throughout the titration were fit simultaneously to this equation with the
program OriginPro 8, extracting a single Kd and multiple D(H,N)max values.
Values for DG were calculated from Kd.
Data are presented throughout the paper as the Kd value ± the error from
the fitting procedure. The other source of error in these experiments
would be concentration errors, but they are not reported due to difficulty in
estimating them. However, experience indicates that these errors in Kd due toStructure 18, 1654–16talin concentration determination would at most be about 10% (correspond-
ing to a maximum error in DG of 0.25 kJ/mol). For interactions with Kd values
less than about 100 mM, this would be compounded by b-integrin con-
centration determination errors, leading to a maximum total Kd error due to
concentration errors of about 20% (corresponding to a maximum error in
DG of 0.5 kJ/mol).
Some Kd values are reported as approximate because bindingwas tooweak
for the generation of a full binding curve. In these cases the value of D(H,N)max
was estimated by comparing maximum D(H,N) values for peaks unaffected by
the given mutation to D(H,N) of peaks in the corresponding WT titration. The
fitting procedure was then carried out as before but with the value ofD(H,N)max
restrained. No errors are reported for these values because they are only
estimates.
ITC
ITC was performed on a MicroCal iTC200 calorimeter with integrin b tail
peptide in the instrument cell (200 ml) and talin in the injection syringe66, December 8, 2010 ª2010 Elsevier Ltd All rights reserved 1663
Figure 7. b1- and b3-Integrin Tails Differ in Rigidity
and Helical Propensity
(A and B) Comparison of MP regions of b1D (A) and b3 (B)
bound to the Talin2 or Talin1 F3 domain. The image of b3
comes from the b3/PIPK1g chimera/Talin1 structure (PDB
2H7E) (Wegener et al., 2007). Highlighted residues differ
between b3- and b1-integrins.
(C) Plot of the steady-state heteronuclear {1H}-15N NOE effect
versus residue number for the WT b1A, b1D, and b3 tails in the
unbound state. Error bars were generated from spectral noise.
(D) As in (C), but for b1A K768E/K770R and b3 E732K/R734K.
(E) Residue-level predictions fromAgadir (Munoz and Serrano,
1994) of helical content for the WT b1A and b3 tails. See also
Figure S5.
(F) As in (E), but for b1A K768E/K770R and b3 E732K/R734K.
Structure
Integrin/Talin Interaction Structural Diversity(40 ml). Experiments were carried out at 25C in NMR buffer. For the titration
of b1D WT with Talin2 F3, the cell contained 139–149 mM integrin, the
syringe contained 1.87–1.99 mM talin, and sixteen 2.5 ml injections were
performed (5 s each, separated by 180 s intervals). For the titration of
b1D (D776/T777/Q778)V with Talin2 F3, the cell contained 5 mM integrin,
the syringe contained 50 mM talin, and twenty 2 ml injections were performed
(4 s each, separated by 180 s intervals). Experimental data were analyzed
using MicroCal Origin software. Kd values were calculated from affinity
constants.Helical Propensity Prediction
Helical propensity was predicted by Agadir (Munoz and Serrano, 1994),
through its web interface (http://agadir.crg.es). The full integrin tail peptide
sequence (WT or mutant) was provided as input, and adjustable parameters
were chosen to match experimental conditions ([pH 6.1] 298 K temperature,
0.2 M ionic strength). Output is presented as the predicted helical content
either for the full peptide or on a residue-by-residue basis.1664 Structure 18, 1654–1666, December 8, 2010 ª2010 Elsevier LtdSUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at doi:10.1016/j.str.2010.09.018.
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